 | • レポートコード：MRC308GR11377 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のダビガトランエテキシレートカプセルの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のダビガトランエテキシレートカプセル市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– ダビガトランエテキシレートカプセルの成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
ダビガトランエテキシレートカプセル市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・110mg/カプセル、150mg/カプセル
用途別セグメント
・病院、診療所、薬局
主要な市場プレーヤー
・Boehringer Ingelheim Pharma、Apotex、Camber Pharmaceuticals、MSN Laboratories、Jiwan Pharmaceutical Technology、Chia Tai Tianqing Pharmaceutical、Hansoh Pharmaceutical、Nanjing Haichen Pharmaceutical、Qilu Pharmaceutical、Chengdu Easton Biopharmaceuticals
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、ダビガトランエテキシレートカプセル製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なダビガトランエテキシレートカプセルメーカーの企業概要、2019年～2022年までのダビガトランエテキシレートカプセルの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なダビガトランエテキシレートカプセルメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ダビガトランエテキシレートカプセルの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのダビガトランエテキシレートカプセルの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのダビガトランエテキシレートカプセル市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびダビガトランエテキシレートカプセルの産業チェーンを掲載しています。
・第14、15章では、ダビガトランエテキシレートカプセルの販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– ダビガトランエテキシレートカプセルの概要
– 種類別分析（2018年vs2022年vs2029年）：110mg/カプセル、150mg/カプセル
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、薬局
– 世界のダビガトランエテキシレートカプセル市場規模・予測
– 世界のダビガトランエテキシレートカプセル生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Boehringer Ingelheim Pharma、Apotex、Camber Pharmaceuticals、MSN Laboratories、Jiwan Pharmaceutical Technology、Chia Tai Tianqing Pharmaceutical、Hansoh Pharmaceutical、Nanjing Haichen Pharmaceutical、Qilu Pharmaceutical、Chengdu Easton Biopharmaceuticals
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：110mg/カプセル、150mg/カプセル
・用途別分析2018年-2029年：病院、診療所、薬局
・ダビガトランエテキシレートカプセルの北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ダビガトランエテキシレートカプセルのヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ダビガトランエテキシレートカプセルのアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ダビガトランエテキシレートカプセルの南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ダビガトランエテキシレートカプセルの中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Dabigatran Etexilate Capsules
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Dabigatran Etexilate Capsules Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 110mg/Capsule
1.3.3 150mg/Capsule
1.4 Market Analysis by Application
1.4.1 Overview: Global Dabigatran Etexilate Capsules Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Pharmacy
1.5 Global Dabigatran Etexilate Capsules Market Size & Forecast
1.5.1 Global Dabigatran Etexilate Capsules Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Dabigatran Etexilate Capsules Sales Quantity (2018-2029)
1.5.3 Global Dabigatran Etexilate Capsules Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Boehringer Ingelheim Pharma
2.1.1 Boehringer Ingelheim Pharma Details
2.1.2 Boehringer Ingelheim Pharma Major Business
2.1.3 Boehringer Ingelheim Pharma Dabigatran Etexilate Capsules Product and Services
2.1.4 Boehringer Ingelheim Pharma Dabigatran Etexilate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Boehringer Ingelheim Pharma Recent Developments/Updates
2.2 Apotex
2.2.1 Apotex Details
2.2.2 Apotex Major Business
2.2.3 Apotex Dabigatran Etexilate Capsules Product and Services
2.2.4 Apotex Dabigatran Etexilate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Apotex Recent Developments/Updates
2.3 Camber Pharmaceuticals
2.3.1 Camber Pharmaceuticals Details
2.3.2 Camber Pharmaceuticals Major Business
2.3.3 Camber Pharmaceuticals Dabigatran Etexilate Capsules Product and Services
2.3.4 Camber Pharmaceuticals Dabigatran Etexilate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Camber Pharmaceuticals Recent Developments/Updates
2.4 MSN Laboratories
2.4.1 MSN Laboratories Details
2.4.2 MSN Laboratories Major Business
2.4.3 MSN Laboratories Dabigatran Etexilate Capsules Product and Services
2.4.4 MSN Laboratories Dabigatran Etexilate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 MSN Laboratories Recent Developments/Updates
2.5 Jiwan Pharmaceutical Technology
2.5.1 Jiwan Pharmaceutical Technology Details
2.5.2 Jiwan Pharmaceutical Technology Major Business
2.5.3 Jiwan Pharmaceutical Technology Dabigatran Etexilate Capsules Product and Services
2.5.4 Jiwan Pharmaceutical Technology Dabigatran Etexilate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Jiwan Pharmaceutical Technology Recent Developments/Updates
2.6 Chia Tai Tianqing Pharmaceutical
2.6.1 Chia Tai Tianqing Pharmaceutical Details
2.6.2 Chia Tai Tianqing Pharmaceutical Major Business
2.6.3 Chia Tai Tianqing Pharmaceutical Dabigatran Etexilate Capsules Product and Services
2.6.4 Chia Tai Tianqing Pharmaceutical Dabigatran Etexilate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
2.7 Hansoh Pharmaceutical
2.7.1 Hansoh Pharmaceutical Details
2.7.2 Hansoh Pharmaceutical Major Business
2.7.3 Hansoh Pharmaceutical Dabigatran Etexilate Capsules Product and Services
2.7.4 Hansoh Pharmaceutical Dabigatran Etexilate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hansoh Pharmaceutical Recent Developments/Updates
2.8 Nanjing Haichen Pharmaceutical
2.8.1 Nanjing Haichen Pharmaceutical Details
2.8.2 Nanjing Haichen Pharmaceutical Major Business
2.8.3 Nanjing Haichen Pharmaceutical Dabigatran Etexilate Capsules Product and Services
2.8.4 Nanjing Haichen Pharmaceutical Dabigatran Etexilate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Nanjing Haichen Pharmaceutical Recent Developments/Updates
2.9 Qilu Pharmaceutical
2.9.1 Qilu Pharmaceutical Details
2.9.2 Qilu Pharmaceutical Major Business
2.9.3 Qilu Pharmaceutical Dabigatran Etexilate Capsules Product and Services
2.9.4 Qilu Pharmaceutical Dabigatran Etexilate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Qilu Pharmaceutical Recent Developments/Updates
2.10 Chengdu Easton Biopharmaceuticals
2.10.1 Chengdu Easton Biopharmaceuticals Details
2.10.2 Chengdu Easton Biopharmaceuticals Major Business
2.10.3 Chengdu Easton Biopharmaceuticals Dabigatran Etexilate Capsules Product and Services
2.10.4 Chengdu Easton Biopharmaceuticals Dabigatran Etexilate Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Chengdu Easton Biopharmaceuticals Recent Developments/Updates
3 Competitive Environment: Dabigatran Etexilate Capsules by Manufacturer
3.1 Global Dabigatran Etexilate Capsules Sales Quantity by Manufacturer (2018-2023)
3.2 Global Dabigatran Etexilate Capsules Revenue by Manufacturer (2018-2023)
3.3 Global Dabigatran Etexilate Capsules Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Dabigatran Etexilate Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Dabigatran Etexilate Capsules Manufacturer Market Share in 2022
3.4.2 Top 6 Dabigatran Etexilate Capsules Manufacturer Market Share in 2022
3.5 Dabigatran Etexilate Capsules Market: Overall Company Footprint Analysis
3.5.1 Dabigatran Etexilate Capsules Market: Region Footprint
3.5.2 Dabigatran Etexilate Capsules Market: Company Product Type Footprint
3.5.3 Dabigatran Etexilate Capsules Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Dabigatran Etexilate Capsules Market Size by Region
4.1.1 Global Dabigatran Etexilate Capsules Sales Quantity by Region (2018-2029)
4.1.2 Global Dabigatran Etexilate Capsules Consumption Value by Region (2018-2029)
4.1.3 Global Dabigatran Etexilate Capsules Average Price by Region (2018-2029)
4.2 North America Dabigatran Etexilate Capsules Consumption Value (2018-2029)
4.3 Europe Dabigatran Etexilate Capsules Consumption Value (2018-2029)
4.4 Asia-Pacific Dabigatran Etexilate Capsules Consumption Value (2018-2029)
4.5 South America Dabigatran Etexilate Capsules Consumption Value (2018-2029)
4.6 Middle East and Africa Dabigatran Etexilate Capsules Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Dabigatran Etexilate Capsules Sales Quantity by Type (2018-2029)
5.2 Global Dabigatran Etexilate Capsules Consumption Value by Type (2018-2029)
5.3 Global Dabigatran Etexilate Capsules Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Dabigatran Etexilate Capsules Sales Quantity by Application (2018-2029)
6.2 Global Dabigatran Etexilate Capsules Consumption Value by Application (2018-2029)
6.3 Global Dabigatran Etexilate Capsules Average Price by Application (2018-2029)
7 North America
7.1 North America Dabigatran Etexilate Capsules Sales Quantity by Type (2018-2029)
7.2 North America Dabigatran Etexilate Capsules Sales Quantity by Application (2018-2029)
7.3 North America Dabigatran Etexilate Capsules Market Size by Country
7.3.1 North America Dabigatran Etexilate Capsules Sales Quantity by Country (2018-2029)
7.3.2 North America Dabigatran Etexilate Capsules Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Dabigatran Etexilate Capsules Sales Quantity by Type (2018-2029)
8.2 Europe Dabigatran Etexilate Capsules Sales Quantity by Application (2018-2029)
8.3 Europe Dabigatran Etexilate Capsules Market Size by Country
8.3.1 Europe Dabigatran Etexilate Capsules Sales Quantity by Country (2018-2029)
8.3.2 Europe Dabigatran Etexilate Capsules Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Dabigatran Etexilate Capsules Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Dabigatran Etexilate Capsules Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Dabigatran Etexilate Capsules Market Size by Region
9.3.1 Asia-Pacific Dabigatran Etexilate Capsules Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Dabigatran Etexilate Capsules Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Dabigatran Etexilate Capsules Sales Quantity by Type (2018-2029)
10.2 South America Dabigatran Etexilate Capsules Sales Quantity by Application (2018-2029)
10.3 South America Dabigatran Etexilate Capsules Market Size by Country
10.3.1 South America Dabigatran Etexilate Capsules Sales Quantity by Country (2018-2029)
10.3.2 South America Dabigatran Etexilate Capsules Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Dabigatran Etexilate Capsules Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Dabigatran Etexilate Capsules Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Dabigatran Etexilate Capsules Market Size by Country
11.3.1 Middle East & Africa Dabigatran Etexilate Capsules Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Dabigatran Etexilate Capsules Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Dabigatran Etexilate Capsules Market Drivers
12.2 Dabigatran Etexilate Capsules Market Restraints
12.3 Dabigatran Etexilate Capsules Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Dabigatran Etexilate Capsules and Key Manufacturers
13.2 Manufacturing Costs Percentage of Dabigatran Etexilate Capsules
13.3 Dabigatran Etexilate Capsules Production Process
13.4 Dabigatran Etexilate Capsules Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Dabigatran Etexilate Capsules Typical Distributors
14.3 Dabigatran Etexilate Capsules Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Dabigatran Etexilate Capsules Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Dabigatran Etexilate Capsules Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Boehringer Ingelheim Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer Ingelheim Pharma Major Business
Table 5. Boehringer Ingelheim Pharma Dabigatran Etexilate Capsules Product and Services
Table 6. Boehringer Ingelheim Pharma Dabigatran Etexilate Capsules Sales Quantity (Bottles), Average Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Boehringer Ingelheim Pharma Recent Developments/Updates
Table 8. Apotex Basic Information, Manufacturing Base and Competitors
Table 9. Apotex Major Business
Table 10. Apotex Dabigatran Etexilate Capsules Product and Services
Table 11. Apotex Dabigatran Etexilate Capsules Sales Quantity (Bottles), Average Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Apotex Recent Developments/Updates
Table 13. Camber Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Camber Pharmaceuticals Major Business
Table 15. Camber Pharmaceuticals Dabigatran Etexilate Capsules Product and Services
Table 16. Camber Pharmaceuticals Dabigatran Etexilate Capsules Sales Quantity (Bottles), Average Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Camber Pharmaceuticals Recent Developments/Updates
Table 18. MSN Laboratories Basic Information, Manufacturing Base and Competitors
Table 19. MSN Laboratories Major Business
Table 20. MSN Laboratories Dabigatran Etexilate Capsules Product and Services
Table 21. MSN Laboratories Dabigatran Etexilate Capsules Sales Quantity (Bottles), Average Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. MSN Laboratories Recent Developments/Updates
Table 23. Jiwan Pharmaceutical Technology Basic Information, Manufacturing Base and Competitors
Table 24. Jiwan Pharmaceutical Technology Major Business
Table 25. Jiwan Pharmaceutical Technology Dabigatran Etexilate Capsules Product and Services
Table 26. Jiwan Pharmaceutical Technology Dabigatran Etexilate Capsules Sales Quantity (Bottles), Average Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Jiwan Pharmaceutical Technology Recent Developments/Updates
Table 28. Chia Tai Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Chia Tai Tianqing Pharmaceutical Major Business
Table 30. Chia Tai Tianqing Pharmaceutical Dabigatran Etexilate Capsules Product and Services
Table 31. Chia Tai Tianqing Pharmaceutical Dabigatran Etexilate Capsules Sales Quantity (Bottles), Average Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 33. Hansoh Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Hansoh Pharmaceutical Major Business
Table 35. Hansoh Pharmaceutical Dabigatran Etexilate Capsules Product and Services
Table 36. Hansoh Pharmaceutical Dabigatran Etexilate Capsules Sales Quantity (Bottles), Average Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hansoh Pharmaceutical Recent Developments/Updates
Table 38. Nanjing Haichen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Nanjing Haichen Pharmaceutical Major Business
Table 40. Nanjing Haichen Pharmaceutical Dabigatran Etexilate Capsules Product and Services
Table 41. Nanjing Haichen Pharmaceutical Dabigatran Etexilate Capsules Sales Quantity (Bottles), Average Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Nanjing Haichen Pharmaceutical Recent Developments/Updates
Table 43. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Qilu Pharmaceutical Major Business
Table 45. Qilu Pharmaceutical Dabigatran Etexilate Capsules Product and Services
Table 46. Qilu Pharmaceutical Dabigatran Etexilate Capsules Sales Quantity (Bottles), Average Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Qilu Pharmaceutical Recent Developments/Updates
Table 48. Chengdu Easton Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Chengdu Easton Biopharmaceuticals Major Business
Table 50. Chengdu Easton Biopharmaceuticals Dabigatran Etexilate Capsules Product and Services
Table 51. Chengdu Easton Biopharmaceuticals Dabigatran Etexilate Capsules Sales Quantity (Bottles), Average Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Chengdu Easton Biopharmaceuticals Recent Developments/Updates
Table 53. Global Dabigatran Etexilate Capsules Sales Quantity by Manufacturer (2018-2023) & (Bottles)
Table 54. Global Dabigatran Etexilate Capsules Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Dabigatran Etexilate Capsules Average Price by Manufacturer (2018-2023) & (US$/Bottle)
Table 56. Market Position of Manufacturers in Dabigatran Etexilate Capsules, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Dabigatran Etexilate Capsules Production Site of Key Manufacturer
Table 58. Dabigatran Etexilate Capsules Market: Company Product Type Footprint
Table 59. Dabigatran Etexilate Capsules Market: Company Product Application Footprint
Table 60. Dabigatran Etexilate Capsules New Market Entrants and Barriers to Market Entry
Table 61. Dabigatran Etexilate Capsules Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Dabigatran Etexilate Capsules Sales Quantity by Region (2018-2023) & (Bottles)
Table 63. Global Dabigatran Etexilate Capsules Sales Quantity by Region (2024-2029) & (Bottles)
Table 64. Global Dabigatran Etexilate Capsules Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Dabigatran Etexilate Capsules Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Dabigatran Etexilate Capsules Average Price by Region (2018-2023) & (US$/Bottle)
Table 67. Global Dabigatran Etexilate Capsules Average Price by Region (2024-2029) & (US$/Bottle)
Table 68. Global Dabigatran Etexilate Capsules Sales Quantity by Type (2018-2023) & (Bottles)
Table 69. Global Dabigatran Etexilate Capsules Sales Quantity by Type (2024-2029) & (Bottles)
Table 70. Global Dabigatran Etexilate Capsules Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Dabigatran Etexilate Capsules Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Dabigatran Etexilate Capsules Average Price by Type (2018-2023) & (US$/Bottle)
Table 73. Global Dabigatran Etexilate Capsules Average Price by Type (2024-2029) & (US$/Bottle)
Table 74. Global Dabigatran Etexilate Capsules Sales Quantity by Application (2018-2023) & (Bottles)
Table 75. Global Dabigatran Etexilate Capsules Sales Quantity by Application (2024-2029) & (Bottles)
Table 76. Global Dabigatran Etexilate Capsules Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Dabigatran Etexilate Capsules Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Dabigatran Etexilate Capsules Average Price by Application (2018-2023) & (US$/Bottle)
Table 79. Global Dabigatran Etexilate Capsules Average Price by Application (2024-2029) & (US$/Bottle)
Table 80. North America Dabigatran Etexilate Capsules Sales Quantity by Type (2018-2023) & (Bottles)
Table 81. North America Dabigatran Etexilate Capsules Sales Quantity by Type (2024-2029) & (Bottles)
Table 82. North America Dabigatran Etexilate Capsules Sales Quantity by Application (2018-2023) & (Bottles)
Table 83. North America Dabigatran Etexilate Capsules Sales Quantity by Application (2024-2029) & (Bottles)
Table 84. North America Dabigatran Etexilate Capsules Sales Quantity by Country (2018-2023) & (Bottles)
Table 85. North America Dabigatran Etexilate Capsules Sales Quantity by Country (2024-2029) & (Bottles)
Table 86. North America Dabigatran Etexilate Capsules Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Dabigatran Etexilate Capsules Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Dabigatran Etexilate Capsules Sales Quantity by Type (2018-2023) & (Bottles)
Table 89. Europe Dabigatran Etexilate Capsules Sales Quantity by Type (2024-2029) & (Bottles)
Table 90. Europe Dabigatran Etexilate Capsules Sales Quantity by Application (2018-2023) & (Bottles)
Table 91. Europe Dabigatran Etexilate Capsules Sales Quantity by Application (2024-2029) & (Bottles)
Table 92. Europe Dabigatran Etexilate Capsules Sales Quantity by Country (2018-2023) & (Bottles)
Table 93. Europe Dabigatran Etexilate Capsules Sales Quantity by Country (2024-2029) & (Bottles)
Table 94. Europe Dabigatran Etexilate Capsules Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Dabigatran Etexilate Capsules Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Dabigatran Etexilate Capsules Sales Quantity by Type (2018-2023) & (Bottles)
Table 97. Asia-Pacific Dabigatran Etexilate Capsules Sales Quantity by Type (2024-2029) & (Bottles)
Table 98. Asia-Pacific Dabigatran Etexilate Capsules Sales Quantity by Application (2018-2023) & (Bottles)
Table 99. Asia-Pacific Dabigatran Etexilate Capsules Sales Quantity by Application (2024-2029) & (Bottles)
Table 100. Asia-Pacific Dabigatran Etexilate Capsules Sales Quantity by Region (2018-2023) & (Bottles)
Table 101. Asia-Pacific Dabigatran Etexilate Capsules Sales Quantity by Region (2024-2029) & (Bottles)
Table 102. Asia-Pacific Dabigatran Etexilate Capsules Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Dabigatran Etexilate Capsules Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Dabigatran Etexilate Capsules Sales Quantity by Type (2018-2023) & (Bottles)
Table 105. South America Dabigatran Etexilate Capsules Sales Quantity by Type (2024-2029) & (Bottles)
Table 106. South America Dabigatran Etexilate Capsules Sales Quantity by Application (2018-2023) & (Bottles)
Table 107. South America Dabigatran Etexilate Capsules Sales Quantity by Application (2024-2029) & (Bottles)
Table 108. South America Dabigatran Etexilate Capsules Sales Quantity by Country (2018-2023) & (Bottles)
Table 109. South America Dabigatran Etexilate Capsules Sales Quantity by Country (2024-2029) & (Bottles)
Table 110. South America Dabigatran Etexilate Capsules Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Dabigatran Etexilate Capsules Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Dabigatran Etexilate Capsules Sales Quantity by Type (2018-2023) & (Bottles)
Table 113. Middle East & Africa Dabigatran Etexilate Capsules Sales Quantity by Type (2024-2029) & (Bottles)
Table 114. Middle East & Africa Dabigatran Etexilate Capsules Sales Quantity by Application (2018-2023) & (Bottles)
Table 115. Middle East & Africa Dabigatran Etexilate Capsules Sales Quantity by Application (2024-2029) & (Bottles)
Table 116. Middle East & Africa Dabigatran Etexilate Capsules Sales Quantity by Region (2018-2023) & (Bottles)
Table 117. Middle East & Africa Dabigatran Etexilate Capsules Sales Quantity by Region (2024-2029) & (Bottles)
Table 118. Middle East & Africa Dabigatran Etexilate Capsules Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Dabigatran Etexilate Capsules Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Dabigatran Etexilate Capsules Raw Material
Table 121. Key Manufacturers of Dabigatran Etexilate Capsules Raw Materials
Table 122. Dabigatran Etexilate Capsules Typical Distributors
Table 123. Dabigatran Etexilate Capsules Typical Customers
List of Figures
Figure 1. Dabigatran Etexilate Capsules Picture
Figure 2. Global Dabigatran Etexilate Capsules Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Dabigatran Etexilate Capsules Consumption Value Market Share by Type in 2022
Figure 4. 110mg/Capsule Examples
Figure 5. 150mg/Capsule Examples
Figure 6. Global Dabigatran Etexilate Capsules Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Dabigatran Etexilate Capsules Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Pharmacy Examples
Figure 11. Global Dabigatran Etexilate Capsules Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Dabigatran Etexilate Capsules Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Dabigatran Etexilate Capsules Sales Quantity (2018-2029) & (Bottles)
Figure 14. Global Dabigatran Etexilate Capsules Average Price (2018-2029) & (US$/Bottle)
Figure 15. Global Dabigatran Etexilate Capsules Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Dabigatran Etexilate Capsules Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Dabigatran Etexilate Capsules by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Dabigatran Etexilate Capsules Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Dabigatran Etexilate Capsules Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Dabigatran Etexilate Capsules Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Dabigatran Etexilate Capsules Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Dabigatran Etexilate Capsules Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Dabigatran Etexilate Capsules Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Dabigatran Etexilate Capsules Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Dabigatran Etexilate Capsules Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Dabigatran Etexilate Capsules Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Dabigatran Etexilate Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Dabigatran Etexilate Capsules Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Dabigatran Etexilate Capsules Average Price by Type (2018-2029) & (US$/Bottle)
Figure 30. Global Dabigatran Etexilate Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Dabigatran Etexilate Capsules Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Dabigatran Etexilate Capsules Average Price by Application (2018-2029) & (US$/Bottle)
Figure 33. North America Dabigatran Etexilate Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Dabigatran Etexilate Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Dabigatran Etexilate Capsules Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Dabigatran Etexilate Capsules Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Dabigatran Etexilate Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Dabigatran Etexilate Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Dabigatran Etexilate Capsules Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Dabigatran Etexilate Capsules Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Dabigatran Etexilate Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Dabigatran Etexilate Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Dabigatran Etexilate Capsules Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Dabigatran Etexilate Capsules Consumption Value Market Share by Region (2018-2029)
Figure 53. China Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Dabigatran Etexilate Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Dabigatran Etexilate Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Dabigatran Etexilate Capsules Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Dabigatran Etexilate Capsules Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Dabigatran Etexilate Capsules Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Dabigatran Etexilate Capsules Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Dabigatran Etexilate Capsules Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Dabigatran Etexilate Capsules Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Dabigatran Etexilate Capsules Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Dabigatran Etexilate Capsules Market Drivers
Figure 74. Dabigatran Etexilate Capsules Market Restraints
Figure 75. Dabigatran Etexilate Capsules Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Dabigatran Etexilate Capsules in 2022
Figure 78. Manufacturing Process Analysis of Dabigatran Etexilate Capsules
Figure 79. Dabigatran Etexilate Capsules Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source